Overview of the blood compatibility of nanomedicines: A trend analysis of in vitro and in vivo studies (Q90579730)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30556649 AND SRC:MED&resulttype=core&format=json

14 April 2020

title

Overview of the blood compatibility of nanomedicines: A trend analysis of in vitro and in vivo studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30556649 AND SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

Patricia Urbán

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30556649 AND SRC:MED&resulttype=core&format=json

14 April 2020

Neill J Liptrott

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30556649 AND SRC:MED&resulttype=core&format=json

14 April 2020

Susanne Bremer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30556649 AND SRC:MED&resulttype=core&format=json

14 April 2020

publication date

17 December 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30556649 AND SRC:MED&resulttype=core&format=json

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

14 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30556649 AND SRC:MED&resulttype=core&format=json

14 April 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30556649 AND SRC:MED&resulttype=core&format=json

14 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30556649 AND SRC:MED&resulttype=core&format=json

14 April 2020

page(s)

e1546

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30556649 AND SRC:MED&resulttype=core&format=json

Harmonization of animal clinical pathology testing in toxicity and safety studies. The Joint Scientific Committee for International Harmonization of Clinical Pathology Testing

14 April 2020

cites work

1 reference

12 December 2020

Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo

1 reference

12 December 2020

Platelet counting by the RBC/platelet ratio method. A reference method

1 reference

12 December 2020

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions

1 reference

12 December 2020

Influence of PAMAM dendrimers on human red blood cells

1 reference

12 December 2020

Can the pharmaceutical industry reduce attrition rates?

1 reference

12 December 2020

Nanoparticle-induced platelet aggregation and vascular thrombosis

1 reference

12 December 2020

PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery

1 reference

12 December 2020

Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake

1 reference

12 December 2020

Complement and coagulation: strangers or partners in crime?

1 reference

12 December 2020

Exploiting lymphatic transport and complement activation in nanoparticle vaccines

1 reference

12 December 2020

Characterization of nanoparticles for therapeutics

1 reference

12 December 2020

Surface chemistry influences implant biocompatibility

1 reference

12 December 2020

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution

1 reference

12 December 2020

Method for analysis of nanoparticle hemolytic properties in vitro

1 reference

12 December 2020

Nanotoxicity of TiO(2) nanoparticles to erythrocyte in vitro

1 reference

12 December 2020

Nanoparticles of a different source induce different patterns of activation in key biochemical and cellular components of the host response

1 reference

12 December 2020

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

1 reference

12 December 2020

The role of nanoparticle size in hemocompatibility.

1 reference

12 December 2020

Characterization of antiplatelet properties of silver nanoparticles

1 reference

12 December 2020

Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications

1 reference

12 December 2020

Protein adsorption and complement activation for di-block copolymer nanoparticles

1 reference

12 December 2020

Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation

1 reference

12 December 2020

Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.

1 reference

12 December 2020

Validation of the calibrated thrombin generation test (cTGT) as the reference assay to evaluate the procoagulant activity of nanomaterials

1 reference

12 December 2020

Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles

1 reference

12 December 2020

Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention

1 reference

12 December 2020

Nanoparticle Size and Surface Charge Determine Effects of PAMAM Dendrimers on Human Platelets in Vitro

1 reference

12 December 2020

Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses

1 reference

12 December 2020

Challenges in development of nanoparticle-based therapeutics

1 reference

12 December 2020

Nanoparticles induce platelet activation in vitro through stimulation of canonical signalling pathways

1 reference

12 December 2020

Toward a reference method for leukocyte differential counts in blood: comparison of three flow cytometric candidate methods

1 reference

12 December 2020

Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials

1 reference

12 December 2020

Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology

1 reference

12 December 2020

Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines

1 reference

12 December 2020

Implementation of alternative test strategies for the safety assessment of engineered nanomaterials

1 reference

12 December 2020

Nanosafety: towards safer design of nanomedicines

1 reference

12 December 2020

Obstacles in haemocompatibility testing

1 reference

12 December 2020

Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles

1 reference

12 December 2020

ICSH guidelines for the evaluation of blood cell analysers including those used for differential leucocyte and reticulocyte counting

1 reference

12 December 2020

Are there sufficient standards for the in vitro hemocompatibility testing of biomaterials?

1 reference

12 December 2020

Issues and concerns in nanotech product development and its commercialization.

1 reference

12 December 2020

Size-dependent effects of nanoparticles on enzymes in the blood coagulation cascade

1 reference

12 December 2020

Nanoparticles for cancer imaging: The good, the bad, and the promise

1 reference

12 December 2020

Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications

1 reference

12 December 2020

Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity

1 reference

12 December 2020

Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics

1 reference

12 December 2020

Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs

1 reference

12 December 2020

Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood.

1 reference

12 December 2020

Current understanding of interactions between nanoparticles and the immune system

1 reference

12 December 2020

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

1 reference

12 December 2020

An Evaluation of Blood Compatibility of Silver Nanoparticles

1 reference

12 December 2020

A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements

1 reference

12 December 2020

Activation of Human Complement System by Dextran-Coated Iron Oxide Nanoparticles Is Not Affected by Dextran/Fe Ratio, Hydroxyl Modifications, and Crosslinking

1 reference

12 December 2020

The nanoparticle protein corona formed in human blood or human blood fractions

1 reference

12 December 2020

The evolving landscape of drug products containing nanomaterials in the United States

1 reference

12 December 2020

ICSH recommendations for modified and alternate methods measuring the erythrocyte sedimentation rate

1 reference

12 December 2020

Mapping of the available standards against the regulatory needs for nanomedicines

1 reference

12 December 2020

Impact of Silver Nanoparticles on Haemolysis, Platelet Function and Coagulation

1 reference

12 December 2020

Main trends of immune effects triggered by nanomedicines in preclinical studies

1 reference

12 December 2020

Identifiers

DOI

10.1002/WNAN.1546

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30556649 AND SRC:MED&resulttype=core&format=json

14 April 2020

1 reference